biotickrTurning Point Therapeutics Inc
The TPTX stock trades on Nasdaq All Markets
Company Description
Oncology,
Meet Precision
Developing targeted cancer therapies to mark a turning point in patients’ lives. We are seeking to develop cancer treatments that are more precise, effective and longer-lasting. We are medicine makers, with deep-rooted expertise in drug discovery and development. Turning Point is made up of decision-makers, but we always act as part of a larger team to drive our mission forward. Our therapies are designed to be different than other cancer medicines, precisely able to target cell signaling processes.
Meet Precision
Developing targeted cancer therapies to mark a turning point in patients’ lives. We are seeking to develop cancer treatments that are more precise, effective and longer-lasting. We are medicine makers, with deep-rooted expertise in drug discovery and development. Turning Point is made up of decision-makers, but we always act as part of a larger team to drive our mission forward. Our therapies are designed to be different than other cancer medicines, precisely able to target cell signaling processes.
Drug Pipeline
Source: Turning Point Therapeutics Inc - 20220924
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
Repotrectinib
Non-Small-Cell Lung Cancer
Phase 2
Solid Tumors
Phase 2
TPX-0022
Solid Tumors
Phase 1
TPX-0046
Solid Tumors
Phase 1
TPX-0131
Non-Small-Cell Lung Cancer
Phase 1
TPX-4589
Solid Tumors
Phase 1
0 Comments on TPTX stock
Newest
Conversation